Angelos Stergiou's Blog
May 19, 2017 · Dr Angelos Stergiou,Angelos Stergiou,CEO Angelos StergiouDr. Angelos Stergiou’s SELLAS Life Sciences Group licensed from Memorial Sloan Kettering Cancer...May 4, 2017 · Angelos Stergiou,Dr Angelos Stergiou,PhysicianDr. Angelos Stergiou is an entrepreneurial physician who is pioneering the field of cancer...April 27, 2017 · Angelos Stergiou,Dr Angelos Stergiou,SELLAS Life SciencesDr. Angelos Stergiou is the Vice Chairman and Chief Executive Officer of SELLAS Life Sciences...About Dr. Angelos Stergiou
Dr. Angelos Stergiou is the CEO and Vice Chairman of SELLAS Life Sciences Group, a leading bio pharmaceutical neoepitope immunotherapy company that is advancing innovative cancer therapies. Throughout his career, Dr. Angelos Stergiou has collaborated with some of the world’s top academic institutions on clinical research endeavors. The Mayo Clinic, University of Heidelberg, New York University, Harvard University, MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center and Cleveland Clinic represent some of many such institutions that he has worked with.